Skip to main content
Clinical Trials/JPRN-jRCTs061230049
JPRN-jRCTs061230049
Recruiting
未知

Efficacy and safety of remimazolam bolus injection during induction of general anesthesia - Remimazolam bolus injection

Miyoshi Hirotsugu0 sites69 target enrollmentAugust 17, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Scheduled non-cardiac surgeries under general anesthesia
Sponsor
Miyoshi Hirotsugu
Enrollment
69
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 17, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Miyoshi Hirotsugu

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients undergoing scheduled non\-cardiac surgeries under general anesthesia
  • 2\. Patients aged 18 to 80
  • 3\. Patients with ASA\-PS classification 1 or 2
  • 4\. Patients with BMI 18\.5 to 30
  • 5\. Patients who can understand our explanation well enough, agree and sign the consent forms of their own will

Exclusion Criteria

  • 1\. Patients with heavy use of alcohol (over 60 g per day)
  • 2\. Patients who have or previously had an addiction to alcohol or any other drugs
  • 3\. Patients with common use of benzodiazepines
  • 4\. Patients with acute angle\-closed glaucoma, myasthenia gravis or hypersensitivity to remimazolam
  • 5\. Patients with severe mental disorders
  • 6\. Patients with encephalopathy
  • 7\. Patients who are pregnant or lactating
  • 8\. Researchers who are directly involved in this study or other clinical studies, or their families
  • 9\. Patients who are judged inappropriate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials